We are live on
!
Find out more
HighTower Advisors Portfolio holdings
AUM
$94.2B
1-Year Est. Return
21.24%
This Fund
S&P 500
This Quarter
Est. Return
-0.3%
1 Year Est. Return
+21.24%
3 Year Est. Return
+66.34%
5 Year Est. Return
+83.36%
10 Year Est. Return
+290.31%
AUM
$73.7B
AUM Growth
+$559M
(+0.76%)
Cap. Flow
+$1.6B
Cap. Flow
% of AUM
2.16%
Top 10 Holdings %
Top 10 Hldgs %
18.47%
Holding
4,123
New
342
Increased
1,586
Reduced
1,609
Closed
399
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$147M |
| 2 |
Vanguard S&P 500 ETF
VOO
|
+$144M |
| 3 |
Schwab US Large-Cap Growth ETF
SCHG
|
+$86.4M |
| 4 |
Vanguard Value ETF
VTV
|
+$82.3M |
| 5 |
LyondellBasell Industries
LYB
|
+$76.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$90M |
| 2 |
ExxonMobil
XOM
|
+$78M |
| 3 |
Amazon
AMZN
|
+$73.8M |
| 4 |
IBM
IBM
|
+$55.8M |
| 5 |
General Motors
GM
|
+$51.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 12.32% |
| 2 | Financials | 10.91% |
| 3 | Consumer Discretionary | 6.07% |
| 4 | Healthcare | 5.9% |
| 5 | Industrials | 4.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
KYNB
3301
Kyntra Bio
KYNB
$28.5M
| $125K | ﹤0.01% |
16,180
+12,060
| +293% | +$145K |
|
3302
Bioventus
BVS
$843M
| $125K | ﹤0.01% |
13,617
| – | – |
|
3303
Falcon's Beyond
FBYD
$513M
| $124K | ﹤0.01% |
+14,266
| New | +$98.6K |
|
|
PHD
3304
DELISTED
Pioneer Floating Rate Fund
PHD
| $124K | ﹤0.01% |
13,097
+210
| +2% | +$2.02K |
|
3305
Adaptive Biotechnologies
ADPT
$3.61B
| $124K | ﹤0.01% |
16,683
-25
| -0.1% | -$192 |
|
|
VFL
3306
DELISTED
abrdn National Municipal Income Fund
VFL
| $122K | ﹤0.01% |
12,052
-2,273
| -16% | -$23.7K |
|
|
GRFS
3307
Grifois
GRFS
$5.27B
| $122K | ﹤0.01% |
17,117
-749
| -4% | -$5.65K |
|
3308
Serina Therapeutics
SER
$31.5M
| $122K | ﹤0.01% |
21,433
-1,000
| -4% | -$4.73K |
|
|
GLO
3309
Clough Global Opportunities Fund
GLO
$248M
| $121K | ﹤0.01% |
24,823
-4,764
| -16% | -$24.5K |
|
3310
Global X Genomics & Biotechnology ETF
GNOM
$78.6M
| $121K | ﹤0.01% |
3,811
+546
| +17% | +$20.7K |
|
3311
Fluence Energy
FLNC
$1.79B
| $121K | ﹤0.01% |
24,949
+6,157
| +33% | +$58.9K |
|
3312
BlackRock Core Bond Trust
BHK
$644M
| $121K | ﹤0.01% |
11,129
-717
| -6% | -$7.57K |
|
|
NMAD
3313
Nomad Power Solutions
NMAD
$81.4M
| $120K | ﹤0.01% |
99,432
| – | – |
|
3314
Intellia Therapeutics
NTLA
$1.49B
| $120K | ﹤0.01% |
16,921
+1,282
| +8% | +$12.9K |
|
3315
Invesco Quality Municipal Securities
IQI
$526M
| $120K | ﹤0.01% |
12,393
-3,200
| -21% | -$31.6K |
|
3316
Rocket Companies
RKT
$38.2B
| $119K | ﹤0.01% |
+9,896
| New | +$128K |
|
3317
Superior Group of Companies
SGC
$195M
| $118K | ﹤0.01% |
10,800
| – | – |
|
3318
Cue Biopharma
CUE
$137M
| $117K | ﹤0.01% |
4,276
| – | – |
|
3319
Stem
STEM
$50M
| $115K | ﹤0.01% |
16,478
-260
| -2% | -$3.01K |
|
3320
Goodyear
GT
$2.04B
| $115K | ﹤0.01% |
12,434
-16,364
| -57% | -$150K |
|
3321
Lucid Motors
LCID
$2.54B
| $115K | ﹤0.01% |
4,733
-2,031
| -30% | -$54.3K |
|
3322
UNIFI
UFI
$121M
| $114K | ﹤0.01% |
23,793
+1,000
| +4% | +$5.61K |
|
3323
Opendoor
OPEN
$3.71B
| $112K | ﹤0.01% |
113,691
+1,637
| +1% | +$2.15K |
|
|
BWG
3324
BrandywineGLOBAL Global Income Opportunities Fund
BWG
$129M
| $111K | ﹤0.01% |
13,306
-4,511
| -25% | -$37.6K |
|
3325
Standard BioTools
LAB
$303M
| $111K | ﹤0.01% |
102,791
+10,000
| +11% | +$14K |
|
Similar funds
HighTower Advisors's Q1 2025 Portfolio in Review
As of Q1 2025, HighTower Advisors held 4,123 positions worth $73.7B, up 0.76% from $73.1B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
HighTower Advisors's Q1 2025 filing shows 342 new, 1,586 increased, 1,609 reduced and 399 closed positions. Its largest new stake was iShares iBonds Dec 2027 Term Corporate ETF: 1,400,628 shares worth $33.9M. The largest sale was Apple, an estimated $90M.
By sector, the portfolio is most concentrated in Technology at 12% of assets, down from 14% a quarter earlier, followed by Financials and Consumer Discretionary.
- HighTower Advisors's largest Q1 2025 buy was iShares iBonds Dec 2027 Term Corporate ETF: 1,400,628 shares worth $33.9M.
- HighTower Advisors added most to iShares Core S&P 500 ETF in Q1 2025, an estimated $147M increase.
- HighTower Advisors's biggest Q1 2025 reduction was Apple, cutting an estimated $90M.
- HighTower Advisors fully exited Independent Bank Group, Inc. in Q1 2025, selling an estimated $15M.
- HighTower Advisors's ten largest holdings make up 18% of its $73.7B portfolio in Q1 2025.
- HighTower Advisors opened 342 new positions and closed 399 in Q1 2025.
- HighTower Advisors's portfolio value rose 0.76% quarter-over-quarter to $73.7B.
Based on HighTower Advisors's 13F filing for Q1 2025, filed 13 May 2025.